Annovis Bio Inc. (ANVS) Fundamentals

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
SHARE INFORMATION
Market CapUS$ 76.904.155
Shares Outstanding8.163.923
Float5.638.000
Percent Float69,06%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -1,90
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions85
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months273.985
Institutional Holdings Percent23,7%
Institutional Sold Previous 3 Months174.251
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months234.395
Insider Holdings Percent32,1
Insider Sold Previous 3 Months118.849
Insider Shares Owned2.621.623
TRADING INFO
52 Week HighUS$ 132,00
52 Week LowUS$ 8,39
52 Week High ChangeUS$ -59,54
21 Day Moving AverageUS$ 10,8676
21 Day Extended Moving AverageUS$ 10,6833
50 Day Moving AverageUS$ 12,2572
50 Day Extended Moving AverageUS$ 12,1795
200 Day Moving AverageUS$ 22,4305
200 Day Extended Moving AverageUS$ 21,2659
10 Day Average Volume39.159
20 Day Average Volume39.635
30 Day Average Volume39.343
50 Day Average Volume39.895
Alpha0.067200
Beta2.1077
Standard Deviation0.460634
R20.072642
7 Day Price ChangeUS$ -1,09
7 Day Percent Change-10,37%
21 Day Price ChangeUS$ -2,30
21 Day Percent Change-19,62%
30 Day Price ChangeUS$ -3,78
30 Day Percent Change-28,64%
Month to Date Price ChangeUS$ -0,02
Month to Date Percent Change-0,21%
Quarter to Date Price ChangeUS$ -3,93
Quarter to Date Percent Change-29,44%
180 Day Price ChangeUS$ -20,59
180 Day Percent Change-68,61%
200 Day Price ChangeUS$ -19,61
200 Day Percent Change-67,55%
Year to Date Price ChangeUS$ -8,16
Year to Date Percent Change-46,42%

Annovis Bio Inc. (ANVS) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,80
Total Debt To Equity0,00
Int Coverage0,00
Current Ratio34,50
Leverage Ratio1,00
Quick Ratio34,00
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-4,40
Enterprise ValueUS$ 34.235.316
Price to Sales0,00
Price to Free Cash-7,90
PE High Last 5 Years0,00
Price To Book1,80
Price To Cash Flow0,00
PE Low Last 5 Years0,00
Price to Tangible Book1,80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-70,23
Return on Equity-74,44
Return on Capital-74,19

Annovis Bio Inc. (ANVS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWithumSmith+Brown, PC
CEOMaria Maccecchini
Emplyoees3
Last AuditUQ
CIK0001477845
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address1055 Westlakes Drive
Suite 300
Berwyn, PA 19312
Websitehttps://www.annovisbio.com
Facsimile+1 610 727-4001
Telephone+1 610 727-3913
Email-
Kürzlich von Ihnen besucht
NYSE
ANVS
Annovis Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V:de D:20220517 04:25:54